Kenilworth, NJ, United States of America

Jeffrey A Misiaszek



 

Average Co-Inventor Count = 18.9

ph-index = 5

Forward Citations = 61(Granted Patents)


Location History:

  • Kenilworth, NJ (US) (2010 - 2014)
  • Somerset, NJ (US) (2016)

Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: The Innovative Contributions of Jeffrey A. Misiaszek

Introduction

Jeffrey A. Misiaszek, based in Kenilworth, New Jersey, is a distinguished inventor known for his significant contributions to the field of pharmaceuticals. With a portfolio of five patents, his work focuses on innovative compounds that address various medical conditions, particularly in the realm of cognitive and neurodegenerative diseases.

Latest Patents

Among his latest patents, Jeffrey has developed iminothiadiazine dioxide compounds that serve as BACE inhibitors, as well as heterocyclic aspartyl protease inhibitors. These inventions present various embodiments, including specific formulations and pharmaceutical compositions designed to inhibit aspartyl protease. The methods associated with these patents aim to treat cardiovascular diseases, manage cognitive and neurodegenerative conditions, and inhibit specific viral and enzymatic actions, including those related to Human Immunodeficiency Virus and protozoal enzymes. His innovative approach also includes the use of these compounds in conjunction with cholinesterase inhibitors or muscarinic agonists and antagonists.

Career Highlights

Jeffrey’s career has been marked by his tenure at renowned pharmaceutical companies such as Merck Sharp & Dohme Corporation and Pharmacopeia Inc. His work during this time has not only led to innovative breakthroughs but has also contributed significantly to the advancement of therapeutic methodologies in the pharmaceutical industry.

Collaborations

Throughout his career, Jeffrey has collaborated with several competent professionals, including Andrew William Stamford and Jared N. Cumming. These partnerships have facilitated the exchange of ideas and expertise, enhancing the innovation process in the projects they undertook together.

Conclusion

In summary, Jeffrey A. Misiaszek exemplifies the spirit of innovation and dedication within the pharmaceutical industry. His contributions through patents and collaborative efforts continue to pave the way for advancements in medical treatments, showcasing the profound impact that inventors can have on improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…